Krishna Institute of Medical Sciences Limited

Krishna Institute of Medical Sciences Limited

Krishna Institute of Medical Sciences Limited has received approval from both BSE and NSE for the listing of 1,98,67,549 equity shares. These shares, with a face value of Rs. 2/- each, were issued to qualified institutional buyers through a Qualified Institutional Placement (QIP). This intimation confirms the successful completion of the regulatory process for the QIP shares to be traded on the exchanges.

Krishna Institute of Medical Sciences Limited

Krishna Institute of Medical Sciences Limited announced that its Finance & Investment Committee met on June 19, 2026. The committee approved matters related to a Qualified Institutions Placement (QIP) of its equity shares. This QIP is being undertaken in accordance with SEBI ICDR Regulations and the Companies Act, 2013. The full details regarding the QIP allotment, such as the number of shares or funds raised, were not completely disclosed in the provided announcement. For investors, this indicates the company is proceeding with its plan to raise capital from institutional investors, potentially strengthening its financial position.

Krishna Institute of Medical Sciences Limited

Krishna Institute of Medical Sciences Limited (KIMS) has issued a general update regarding a proposed Qualified Institutional Placement (QIP) of its equity shares. This announcement follows a previous intimation about a Finance & Investment Committee meeting held to discuss the QIP. The company is exploring issuing equity shares to qualified institutional buyers. While specific financial figures or a final decision are not detailed in this particular update, it signals KIMS's intent to raise capital through this mechanism, potentially impacting the company's share structure for investors.

Krishna Institute of Medical Sciences Limited

Krishna Institute of Medical Sciences Limited (KIMS) has announced a Qualified Institutions Placement (QIP) of its equity shares. This capital raising initiative involves issuing equity shares with a face value of ₹2 each, in compliance with SEBI ICDR Regulations and the Companies Act, 2013. The QIP aims to raise funds, which can be utilized for various corporate purposes such as expansion or debt reduction. For investors, this move indicates a capital infusion for future growth, though it typically leads to a short-term dilution of existing equity.